Results
Baseline patient characteristics and clinical data are summarised in Baseline characteristics of the study sampleTotal study sample, by SCOT randomisation arm and by chemotherapy regimen. The statistical significance of the difference between the groups was assessed with the two-sample BMI, body mass index; CAPOX, capecitabine with oxaliplatin; FOLFOX, fluorouracil with oxaliplatin; IQR, interquartile range; SD, standard deviation.